Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Osteosarcoma resembling osteoblastoma.

F Bertoni, K K Unni, R A McLeod

    Cancer
    |January 15, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Mayo clinic tumor rounds.

    Orthopedics·2014
    Same author

    Inflammation-mediated retinal edema in the rabbit is inhibited by topical nepafenac.

    Inflammation·2003
    Same author

    Determination of travoprost and travoprost free acid in human plasma by electrospray HPLC/MS/MS.

    Journal of pharmaceutical and biomedical analysis·2002
    Same author

    CHK1 frameshift mutations in genetically unstable colorectal and endometrial cancers.

    Genes, chromosomes & cancer·1999
    Same author

    Diagnosis and tumor response in osteosarcoma and Ewing's sarcoma, according to treatment protocols SSG II, SSG VIII, ISG/SSG I, SSG IV and SSG IX.

    Acta orthopaedica Scandinavica. Supplementum·1999
    Same author

    Synovial sarcoma: identification of low and high risk groups.

    Cancer·1999
    Same journal

    Toward exercise as standard care for older cancer survivors.

    Cancer·2026
    Same journal

    Maintenance therapy in gynecologic malignancies: Current and future state.

    Cancer·2026
    Same journal

    Long-term outcomes of evolving treatment regimens in Ewing sarcoma survivors diagnosed 1970-1999: A report from the Childhood Cancer Survivor Study.

    Cancer·2026
    Same journal

    Large-scale osteosarcoma sequencing reveals age-associated genomic architectures.

    Cancer·2026
    Same journal

    EZH2 inhibitor tazemetostat voluntarily withdrawn from market.

    Cancer·2026
    Same journal

    Nivolumab and chemotherapy combination approved for previously untreated Hodgkin lymphoma.

    Cancer·2026
    See all related articles

    Osteosarcomas resembling osteoblastomas are malignant tumors. Key differences include tissue permeation and lack of maturation in osteosarcoma, versus circumscription and peripheral maturation in osteoblastoma.

    Area of Science:

    • Orthopedic Oncology
    • Skeletal Pathology
    • Surgical Pathology

    Background:

    • Osteosarcoma and osteoblastoma are bone tumors with distinct clinical and histological features.
    • Some bone tumors present histological features that overlap between osteosarcoma and osteoblastoma, posing diagnostic challenges.

    Purpose of the Study:

    • To investigate the clinicopathological characteristics of osteosarcomas that histologically resemble osteoblastomas.
    • To identify key features for differentiating these challenging bone tumors.
    • To determine the malignant potential of osteoblastoma-like osteosarcomas.

    Main Methods:

    • Retrospective review of 17 patients diagnosed with osteosarcoma exhibiting osteoblastoma-like histology.
    • Analysis of roentgenographic findings.

    Related Experiment Videos

  • Histopathological evaluation focusing on features differentiating osteosarcoma from osteoblastoma, such as tissue permeation and peripheral maturation.
  • Main Results:

    • The study included 17 patients (9 male, 8 female; ages 11-58).
    • Most cases showed roentgenographic features suggestive of malignancy.
    • Histological differentiation relied on permeation of surrounding tissues and lack of peripheral maturation (osteosarcoma) versus circumscription and peripheral maturation (osteoblastoma).
    • Seven out of 17 patients died from the disease, indicating malignant behavior.

    Conclusions:

    • Osteoblastoma-like osteosarcoma is a distinct entity that should be classified as a malignant tumor.
    • Malignant osteoblastoma and aggressive osteoblastoma are likely variants of osteosarcoma with osteoblastoma-like morphology.
    • Accurate histological differentiation is crucial for appropriate patient management and prognosis.